News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Latest Executive Roundtables|
Asembia 2025 |
Sales Effectiveness
Advertisement
News|Slideshows|May 30, 2025

May Pharmaceutical Industry Movers & Shakers

Author(s)Don Tracy, Associate Editor

A monthly roundup of business and people news in the pharmaceutical industry.

Advertisement

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Advertisement

Related Content

Advertisement

JCA vs. Reality: Europe’s Push for Clinical Harmonization

ByDmitry Goldenberg ,Diane Cosset ,Eleonora Sirena
March 10th 2026
Stock.adobe.com

Senate Democrats Expand Efforts to Expose Details of MFN Pharma Deals

ByMike Hollan
March 10th 2026
Pharmaceutical Executive Daily

Pharmaceutical Executive Daily: FDA Expands Approval of Leucovorin

ByNicholas Jacobus
March 10th 2026
Stock.adobe.com

FDA Approves Leucovorin Without a Clinical Trial for Cerebral Folate Transport Deficiency: Report

ByNicholas Jacobus
March 10th 2026
Stock.adobe.com

FDA Grants Priority Review to Enhertu as Treatment for Patients with HER2-positive Early Breast Cancer

ByNicholas Jacobus
March 10th 2026
Advertisement
Advertisement

Trending on PharmExec

1

AI has Redefined Healthcare Communication — and There’s No Opting Out

2

How FDA's Removal of the Two-Trial Requirement Affects Development Programs

3

FDA Grants Priority Review to Enhertu as Treatment for Patients with HER2-positive Early Breast Cancer

4

Novo Nordisk Signs Deal with Hims & Hers

5

Pharmaceutical Executive Daily: Vinay Prasad Set to Leave CBER for Second Time

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us